Publications by authors named "Prasanna A Yakkala"

Claim this Profile
I
In silico design strategies for tubulin inhibitors for the development of anticancer therapies.
Ahmed Kamal, Prasanna Anjaneyulu Yakkala, Lakshmi Soukya, Sajeli Ahil Begum

Expert Opin Drug Discov· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-targeting inhibitors involving tubulin for the treatment of cancer.
Prasanna Anjaneyulu Yakkala, Ahmed Kamal

Bioorg Chem· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Evaluation of Bis-benzothiazoles as a New Class of Benzothiazoles Targeting DprE1 as Antitubercular Agents.
Rabiya Samoon, Shashikanta Sau, Arnab Roy, Kishan Kumar Parida, Kalicharan Sharma, Prasanna Anjaneyulu Yakkala

ACS Infect Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3K and tankyrase inhibitors as therapeutic targets in colorectal cancer.
Prasanna Anjaneyulu Yakkala, Fatima Naaz, Syed Shafi, Ahmed Kamal

Expert Opin Ther Targets· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update on the development on tubulin inhibitors for the treatment of solid tumors.
Prasanna Anjaneyulu Yakkala, Shaik Rahaman, P S Lakshmi Soukya, Sajeli Ahil Begum, Ahmed Kamal

Expert Opin Ther Targets· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospects of Topoisomerase Inhibitors as Promising Anti-Cancer Agents.
Prasanna Anjaneyulu Yakkala, Naveen Reddy Penumallu, Syed Shafi, Ahmed Kamal

Pharmaceuticals (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicomponent Domino Reaction for Concise Access to 2-Amino-Substituted 1,3,4 Oxadiazoles via Smiles Rearrangement.
Prasanna Anjaneyulu Yakkala, Imran A Khan, Srinivas Reddy Dannarm, Jyoti Aboti, Rajesh Sonti

J Org Chem· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyridine-Based 1,2,4-Triazolo-Tethered Indole Conjugates Potentially Affecting TNKS and PI3K in Colorectal Cancer.
Prasanna A Yakkala, Samir R Panda, Vegi G M Naidu, Syed Shafi, Ahmed Kamal

ACS Med Chem Lett· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Cytotoxic Activity of 1,2,4-Triazolo-Linked -Indolyl Conjugates as Dual Inhibitors of Tankyrase and PI3K.
Prasanna A Yakkala, Samir R Panda, Syed Shafi, V G M Naidu, M Shahar Yar

Molecules· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel approaches for the development of direct KRAS inhibitors: structural insights and drug design.
Kashif Haider, Anku Sharma, M Shahar Yar, Prasanna Anjaneyulu Yakkala, Syed Shafi

Expert Opin Drug Discov· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rh(III)-Catalyzed [3 + 2] Annulation via C-H Activation: Direct Access to Trifluoromethyl-Substituted Indenamines and Aminoindanes.
Bharatkumar Chaudhary, Prashant Auti, Suchita Dattatray Shinde, Prasanna Anjaneyulu Yakkala, Deepesh Giri

Org Lett· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis